logo
SOLB logo

SOLB
Solvay

Transformation Initiatives Will Enhance Future Efficiency And Sustainability

WA
Consensus Narrative from 16 Analysts
Published
December 25 2024
Updated
March 12 2025
Share
WarrenAI's Fair Value
€33.38
2.8% overvalued intrinsic discount
12 Mar
€34.30
Loading
1Y
39.7%
7D
7.0%

Key Takeaways

  • The spinoff and energy transition position Solvay for accelerated transformation, enhancing net margins and aligning with sustainability goals.
  • Operational improvements and targeted growth investments are set to reduce costs and drive earnings, emphasizing digitalization and specialized markets.
  • Tragic accidents and economic volatility challenge revenue growth and margins, while energy transition investments and debt costs strain financial flexibility.

Catalysts

About Solvay
    Provides advanced materials and specialty chemicals worldwide.
What are the underlying business or industry changes driving this perspective?
  • The spinoff from Solvay has created a more streamlined and agile organization, which has exceeded projected cost savings and set the stage for accelerated transformation. This shift is expected to enhance net margins and drive earnings growth.
  • Solvay is undertaking an energy transition for its plants and is on track to meet ambitious sustainability goals. This transition supports revenue growth by aligning with customer demands for sustainable products, and helps maintain competitive advantage, potentially improving net margins.
  • The company is implementing a safety culture transformation program to elevate safety performance, which, while improving workplace safety, can reduce costs associated with accidents and enhance operational efficiency, thus supporting future earnings.
  • Solvay's operational excellence initiatives include plans to achieve significant cost savings through digitalization and optimization of operations. An increase in cost savings targets to €350 million by 2028 is anticipated to improve net margins and earnings.
  • Solvay's strategy includes targeted growth CapEx investments in high-potential markets such as electronic grade hydrogen peroxide and circular silica, offering the potential for revenue growth in specialized markets without extensive capital expenditure.

Solvay Earnings and Revenue Growth

Solvay Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Solvay's revenue will decrease by 0.5% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 4.3% today to 8.2% in 3 years time.
  • Analysts expect earnings to reach €417.2 million (and earnings per share of €3.81) by about March 2028, up from €223.0 million today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 10.2x on those 2028 earnings, down from 16.0x today. This future PE is lower than the current PE for the GB Chemicals industry at 17.9x.
  • Analysts expect the number of shares outstanding to decline by 0.61% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.76%, as per the Simply Wall St company report.

Solvay Future Earnings Per Share Growth

Solvay Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Tragic accidents leading to safety concerns may result in increased costs for safety improvements and potential legal liabilities, potentially impacting net margins.
  • A decline in underlying net sales by 4% and EBITDA by 8% suggests potential ongoing challenges in maintaining revenue growth amidst a volatile economic landscape.
  • Heavy reliance on specific end markets, such as soda ash and silica, which could face price pressure or demand fluctuations, affecting earnings stability.
  • The energy transition investments, while strategically important, involve significant long-term capital commitments that may strain short-term free cash flow.
  • Increased provision cash-outs and rising financing costs associated with debt issuance could impact net earnings and limit financial flexibility.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of €33.375 for Solvay based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €40.0, and the most bearish reporting a price target of just €26.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be €5.1 billion, earnings will come to €417.2 million, and it would be trading on a PE ratio of 10.2x, assuming you use a discount rate of 7.8%.
  • Given the current share price of €34.23, the analyst price target of €33.38 is 2.6% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

Warren A.I. is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by Warren A.I. are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that Warren A.I.'s analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Analyst Price Target Fair Value
€33.4
2.8% overvalued intrinsic discount
Future estimation in
PastFuture-1b13b2014201720202023202520262028Revenue €5.1bEarnings €417.2m
% p.a.
Decrease
Increase
Current revenue growth rate
0.02%
Chemicals revenue growth rate
0.26%